The global antifungals market size is expected to grow from $26.76 billion in 2021 to $30.94 billion in 2022 at a compound annual growth rate (CAGR) of 15.6%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global antifungal market size is expected to reach $51.67 billion in 2026 at a CAGR of 13.7%.
What is the Global Antifungals Market?
The antifungals market consists of sales of antifungal drugs which are used to detect and eliminate fungal pathogens. The fungal pathogens thrive in the body under unhygienic and unclean environments. These drugs are also known as an antimycotic medication, used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others.
Get a Sample of the global antifungals market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=2442&type=smp
What drives the Global Antifungals Market?
A point prevalence survey was conducted in Turkey. According to the survey, antifungal drugs were mostly prescribed in pediatric hematology and oncology (PHO) units (35.2%), followed by neonatal ICUs (NICUs) (19.6%). The other units prescribing antifungal drugs included pediatric services (18.3%), pediatric ICUs (PICUs) (14.6%) and hematopoietic (HSCT) units (7.3%). According to the same survey, the antifungals were used for prophylaxis in 48.8% of patients and about 50% of patients were treated with antifungal drugs based on observation. Among 50% of patients, who were treated post observation, around 18.8% of patients were prescribed an antifungal therapy and 31.2% of patients were targeted for the treatments.
Get the full global antifungals industry report here
https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report
Global Antifungals Market Segments
The global antifungals market is segmented:
By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines
End-User: Hospitals and Clinics, Dermatology Clinics, Others
By Route of Administration: Oral, Parenteral, Topical
By Therapeutic Indication: Aspergillosis, Dermatophytosis, Candidiasis, Others
By Geography: The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Antifungals Global Market Report 2022provides market size and growth forecasts for the global antifungals market, global antifungals market share, antifungals market segments and geographies, antifungals market competitive landscape including leading competitors’ revenues, profiles and market shares. The antifungals market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Antifungals Industry Playersinclude Pfizer, Novartis, Merck & Co., Bayer Healthcare and Abbott Laboratories, Sanofi-Aventis, Kramer Laboratories, Glaxosmithkline Gilead, Enzon Pharmaceuticals Inc. and Basilea Pharmaceutica AG. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
